Talk to the people behind the exciting things we do at Bidwells.

Our people

loader
    Sorry, there were no results for your search. Please try again loader
      What we do/ Our Projects/ 214-240 Cambridge Science Park

      Capturing the attention of the world’s biggest life sciences investors with a market-defining, mid-pandemic science park transaction

      220 Cambridge Science Park

      Size
      160,000 sq ft

      Location
      Cambridge Science Park

      Client
      Legal & General

      With demand for UK life sciences real estate soaring after the sector’s success in combatting the global pandemic, Legal and General’s (L&G) eight-acre office campus disposal sparked a fierce bidding war - and a high profile £100m sale.

      We helped L&G piece together its five-building holding at Cambridge Science Park by advising on its acquisition of buildings 220 and 230, adding to three neighbouring offices already held in its portfolio (buildings 214, 216 and 240).

      An exhaustive asset enhancement programme followed before the fund readied itself to dispose of the carefully assembled assets.

      Launched at the height of the UK’s third national lockdown, the sale drew fierce bidding from global institutions and some of the world’s biggest life sciences real estate investors, resulting in a sale figure just short of £100m.  

      With occupier Amgen consolidating into the newly refurbished 216, vacating 214 and 240, and the other two buildings providing some medium-term income, the purchaser, Brockton Everlast, was delighted to fight off more than 20 bidders to secure this rare Cambridge investment opportunity.   

      Our 2021 research estimated that at the time of sale, the interested parties had the total capacity to invest £5.5bn in life sciences and R&D space across the UK.

      This landmark disposal truly defined the UK’s science and technology real estate market during the Covid-19 pandemic.

      220 CSP, Jagex (2).jpg 230 CSP, Bayer.jpg Amgen, 216, CSP (3).jpg Amgen, 216, CSP.jpg
      220 CSP, Jagex (2).jpg 230 CSP, Bayer.jpg Amgen, 216, CSP (3).jpg Amgen, 216, CSP.jpg

      Share this project

      Key Contact

      Get in touch with our team